INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 37 filers reported holding INMUNE BIO INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,004 | -45.4% | 2,364 | -26.8% | 0.00% | – |
| Q2 2023 | $29,319 | +34.2% | 3,229 | -4.5% | 0.00% | – |
| Q1 2023 | $21,841 | -54.7% | 3,381 | -55.5% | 0.00% | – |
| Q4 2022 | $48,203 | -38.2% | 7,603 | -40.0% | 0.00% | – |
| Q3 2022 | $78,000 | -35.5% | 12,678 | -7.0% | 0.00% | – |
| Q2 2022 | $121,000 | +0.8% | 13,627 | -4.1% | 0.00% | – |
| Q1 2022 | $120,000 | +1.7% | 14,216 | +23.5% | 0.00% | – |
| Q4 2021 | $118,000 | +131.4% | 11,509 | +338.1% | 0.00% | – |
| Q3 2021 | $51,000 | +5000.0% | 2,627 | +4951.9% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 52 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 52 | +30.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 40 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 40 | +73.9% | 0.00% | – |
| Q2 2020 | $0 | – | 23 | +4.5% | 0.00% | – |
| Q1 2020 | $0 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Westside Investment Management, Inc. | 37,105 | $239,703 | 0.07% |
| QUADRANT CAPITAL GROUP LLC | 60,000 | $387,600 | 0.04% |
| Janney Montgomery Scott LLC | 239,448 | $1,547 | 0.01% |
| Financial Advocates Investment Management | 11,500 | $74,290 | 0.01% |
| MAI Capital Management | 19,643 | $126,894 | 0.00% |
| VALLEY NATIONAL ADVISERS INC | 1,000 | $8 | 0.00% |
| NORTHERN TRUST CORP | 20,297 | $131,119 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 9,036 | $58,373 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 143,657 | $928,024 | 0.00% |